hypercholesterolaemia

Showing 1 - 25 of 26

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Arteriosclerosis, Hypercholesterolaemia Trial (MK-0616, Placebo)

Not yet recruiting
  • Arteriosclerosis
  • Hypercholesterolaemia
  • (no location specified)
Aug 17, 2023

Hypercholesterolaemia Trial (MK-0616)

Not yet recruiting
  • Hypercholesterolaemia
  • (no location specified)
Jul 12, 2023

Chart Review of Repatha® in Subjects With Hyperlipidaemia

Completed
  • Hypercholesterolaemia
    • Feldkirch, Austria
    • +183 more
    Jul 15, 2022

    Hypercholesterolaemia, Atherosclerosis Trial (Ezetimibe + Simvastatin, Simvastatin)

    Completed
    • Hypercholesterolaemia
    • Atherosclerosis
    • (no location specified)
    Feb 7, 2022

    Hypercholesterolaemia Trial in Worldwide (Alirocumab SAR236553 (REGN727), Rosuvastatin, Atorvastatin)

    Active, not recruiting
    • Hypercholesterolaemia
    • Alirocumab SAR236553 (REGN727)
    • +12 more
    • Boca Raton, Florida
    • +45 more
    Jan 12, 2022

    Healthy Volunteers, Hypercholesterolaemia Trial in Harrow (NNC0385-0434, Placebo (NNC0385-0434))

    Completed
    • Healthy Volunteers
    • Hypercholesterolaemia
    • Harrow, United Kingdom
      Novo Nordisk Investigational Site
    Dec 29, 2021

    Hypercholesterolaemia Trial in Belgium, France, Netherlands (Echographic measurements, Blood samples)

    Completed
    • Hypercholesterolaemia
    • Echographic measurements
    • Blood samples
    • Afsnee GENT, Belgium
    • +71 more
    Feb 17, 2021

    Study to Evaluate the Safety of Repatha® in Pregnancy

    Terminated
    • Hypercholesterolaemia
    • Pregnancy
      • Camperdown, New South Wales, Australia
      • +47 more
      Dec 21, 2020

      HIV, Hypercholesterolaemia Trial in Nijmegen (raltegravir, Atorvastatin)

      Completed
      • HIV
      • Hypercholesterolaemia
      • Nijmegen, Netherlands
        CRCN Radboud University Nijmegen Medical Centre
      Oct 16, 2020

      Hypercholesterolaemia Trial in Peking (AK102, Placebo)

      Completed
      • Hypercholesterolaemia
      • Peking, China
        Peking Union Medical College Hospital
      Nov 17, 2019

      Hypercholesterolaemia Trial in United States (Alirocumab SAR236553, Current auto-injector device (AI), New auto-injector device

      Completed
      • Hypercholesterolaemia
      • Alirocumab SAR236553
      • +4 more
      • Los Angeles, California
      • +12 more
      Sep 6, 2019

      Hypercholesterolaemia Trial in Worldwide (alirocumab SAR236553 (REGN727), statins, ezetimibe)

      Completed
      • Hypercholesterolaemia
      • alirocumab SAR236553 (REGN727)
      • +6 more
      • Saint Louis, Missouri
      • +15 more
      Aug 15, 2019

      Hypercholesterolaemia Trial in Worldwide (Alirocumab, Placebo, Lipid-Modifying Therapy (LMT))

      Completed
      • Hypercholesterolaemia
      • Encino, California
      • +109 more
      May 1, 2018

      Hypercholesterolaemia Trial in Bragança Paulista (Crestor®, rosuvastatin calcium tablets)

      Completed
      • Hypercholesterolaemia
      • Bragança Paulista, São Paulo, Brazil
        GSK Investigational Site
      Jun 19, 2017

      Hypercholesterolaemia Trial in Electronics City, Bengalore (10mg Ezetimibe, 10 mg Ezetimibe - wash out period)

      Completed
      • Hypercholesterolaemia
      • 10mg Ezetimibe
      • 10 mg Ezetimibe - wash out period
      • Electronics City, Bengalore, India
        GSK Investigational Site
      Jun 19, 2017

      Hypercholesterolaemia Trial in Worldwide (Alirocumab, Placebo (for alirocumab), Lipid Modifying Therapy (LMT))

      Completed
      • Hypercholesterolaemia
      • Bell Gardens, California
      • +34 more
      Sep 27, 2016

      HIV, Hypercholesterolaemia Trial in Barcelona (Switch ritonavir-boosted PI, Continue Ritonavir-boosted PI+Rosuvastatin)

      Completed
      • HIV
      • Hypercholesterolaemia
      • Switch ritonavir-boosted PI
      • Continue Ritonavir-boosted PI+Rosuvastatin
      • Barcelona, Spain
        Hospital Clinic of Barcelona
      Oct 7, 2014

      Hypercholesterolaemia Trial in Antwerp (commercially available nutrition supplement, )

      Completed
      • Hypercholesterolaemia
      • commercially available nutrition supplement
      • placebo
      • Antwerp, Belgie, Belgium
        University of Antwerp
      May 19, 2014

      Patients Treated With HMG-CoA Reductase Inhibitors to Reach

      Completed
      • Hypercholesterolaemia
        • Banja Luka, Bosnia and Herzegovina
        • +13 more
        Feb 4, 2013

        Hypercholesterolaemia Trial in Nantes (Limicol, Placebo)

        Completed
        • Hypercholesterolaemia
        • Limicol
        • Placebo
        • Nantes, France
          Biofortis
        Apr 18, 2012

        (NIS) to Assess Reaching of Cholesterol Target Values in

        Completed
        • Hypercholesterolaemia
          • Biograd na moru, Croatia
          • +26 more
          Mar 19, 2012

          Rosuvastatin, and Atorvastatin and Simvastatin In

          Completed
          • Hypercholesterolaemia
            • Singapore, Singapore
              Research Site
            May 11, 2011

            Hypercholesterolaemia Trial in United Kingdom (Dietary advice, rosuvastatin, atorvastatin)

            Terminated
            • Hypercholesterolaemia
            • Dietary advice
            • +2 more
            • Allerton, United Kingdom
            • +8 more
            Nov 30, 2010

            Hypercholesterolaemic Patients

            Completed
            • Hypercholesterolaemia
              • Alexandroupoli, Greece
              • +5 more
              Oct 2, 2009

              Hypercholesterolaemia Trial (Rosuvastatin)

              Completed
              • Hypercholesterolaemia
              • (no location specified)
              Mar 13, 2009